ライフサイエンスコーパス: noradrenaline

1 LPS) thermogenesis, but a normal response to noradrenaline.

2 dipose tissue-derived leptin and SNS-derived noradrenaline.

3 th muscle contraction in response to binding noradrenaline.

4 creases extracellular levels of dopamine and noradrenaline.

5 adrenergic projections and are responsive to noradrenaline.

6 red both the presence of adult-born cell and noradrenaline.

7 amine agonist ligands such as adrenaline and noradrenaline.

8 of VLPO neurons, which are also inhibited by noradrenaline.

9 nce of neuromodulators, such as dopamine and noradrenaline.

10 , an invertebrate analogue of adrenaline and noradrenaline.

11 inal cord and is the major source of central noradrenaline.

12 ne oxidase A (MAOA) that is known to degrade noradrenaline.

13 s in mice by lowering the bioavailability of noradrenaline.

14 cularly the catecholamines dopamine (DA) and noradrenaline.

15 Similar effects were produced with noradrenaline.

16 ion of terlipressin (2-12 mg/day; n = 60) or noradrenaline (0.5-3.0 mg/h; n = 60).

17 Topical noradrenaline (1 nM) blunted ROV in YM and YF to levels

18 shold stimulation of alphaARs in young mice (noradrenaline; 10(-9) m) depressed ROV most effectively

19 of drugs were higher with terlipressin than noradrenaline (23.3% vs. 8.3%; P = 0.02), but were rever

20 for either dopamine (400 mg amisulpride) or noradrenaline (40 mg propranolol) we examined their spec

21 ia increased plasma adrenaline (26-fold) and noradrenaline (5-fold) in shams but elicited no change i

22 Here we assess the roles of noradrenaline, acetylcholine, and dopamine within a sing

23 Spillover and subsequent pooling of noradrenaline activated distal alpha2-receptors, which p

24 Noradrenaline acts through adrenergic receptors (ARs), o

25 criteria for having vasoplegia and required noradrenaline administration greater than 1 mug.kg.min f

26 As a diffuse neuromodulatory system, noradrenaline affects learning and decision making, cont

27 erived factor, non-esterified fatty acids or noradrenaline (all P > 0.05).

28 Noradrenaline also evoked TRPC1 channel activity and ass

29 he options searched by rats, suggesting that noradrenaline also plays a role in balancing exploration

30 For example, locus coeruleus noradrenaline (also known as norepinephrine) (LC-NE) neu

31 ads to burst release of the neurotransmitter noradrenaline (also known as norepinephrine).

32 a2-adrenoreceptor in complex with a covalent noradrenaline analog and a conformationally selective an

33 ed cells with the capacity to accumulate the noradrenaline analog metaiodobenzylguanidine (MIBG).

34 ut the greatest effort has been in preparing noradrenaline analogs, such as norepinephrine, (11)C-met

35 e wake- and sleep-promoting neuromodulators, noradrenaline and adenosine, respectively.

36 Noradrenaline and adrenaline dose-dependently suppressed

37 Plasma noradrenaline and adrenaline levels rose rapidly with dr

38 their synaptic transmission, the effects of noradrenaline and clonidine were tested on the capsaicin

39 current evidence that synergistic action of noradrenaline and cortisol enables emotional stimuli to

40 The closely related transporters for noradrenaline and dopamine depend on SEC24D.

41 eurons in the locus coeruleus (LC) corelease noradrenaline and dopamine in the hippocampus and that t

42 led, study that examined specific effects of noradrenaline and dopamine on both metacognition and per

43 t experimental studies of the acetylcholine, noradrenaline and dopamine systems in fear learning and

44 g study, we investigate the contributions of noradrenaline and dopamine to episodic memory.

45 sine, the corresponding residue found in the noradrenaline and dopamine transporters, switched the SE

46 associated with region-dependent changes in noradrenaline and GABA levels in key areas of the limbic

47 supporting the hypothesis that tVNS elevates noradrenaline and other arousal-promoting neuromodulator

48 NSSs for dopamine, noradrenaline and serotonin are targeted by the psychost

49 e neurons, resulting in increased release of noradrenaline and serotonin in forebrain areas involved

50 nd found a significant decrease in levels of noradrenaline and the serotonin metabolite 5-hydroxyindo

51 ated pressurized MAs preconstricted 50% with noradrenaline and treated with guanethidine (to inhibit

52 enal function, plasma renin activity, plasma noradrenaline and vasopressin concentration, and serum l

53 plasma levels of catecholamines (adrenaline, noradrenaline) and biomarkers reflecting endothelial dam

54 sruption of the catecholamines (dopamine and noradrenaline) and review the efficacy of catecholaminer

55 re neuromodulatory factors such as dopamine, noradrenaline, and brain-derived neurotrophic factor [3-

56 o examine the in vivo effects of adrenaline, noradrenaline, and cortisol on number and functionality

57 mice resulted in reduced striatal serotonin, noradrenaline, and dopamine concentrations and a signifi

58 drugs (terlipressin, midodrine, octreotide, noradrenaline, and dopamine; alone or in combination) wi

59 cular conductance, increasing jugular venous noradrenaline, and falling arterial carbon dioxide tensi

60 ns that release the monoamines serotonin and noradrenaline, and local vessel dilation is induced by g

61 rictor; terlipressin; midodrine; octreotide; noradrenaline; and norepinephrine.

62 tested against the removal time of 5-HT and noradrenaline applied by microinjection to the NTS.

63 Since the major source of noradrenaline are neurons in the locus coeruleus, we hyp

64 The neurotransmitters dopamine and noradrenaline are often assumed critical in influencing

65 Terlipressin and noradrenaline are routinely used in cirrhosis with HRS a

66 in hippocampus, and suggest novel roles for noradrenaline as a modulator of the hippocampal search p

67 ls of insulin, cortisol, growth hormone, and noradrenaline, as well as hypoglycemic symptoms and cogn

68 T-type channels is significantly elevated by noradrenaline at 8 h and 24 h.

69 nal inhibitory effect through the actions of noradrenaline at spinal alpha2 -adrenoceptors, although

70 -motor nerves and vasoconstriction caused by noradrenaline, ATP and neuropeptode Y release from sympa

71 In the presence of siderophore, noradrenaline augmented transferrin utilization by B. br

72 a cell type selective manner, with 5-HT and noradrenaline being limited to presynaptic cells, GABA b

73 onal substrate and cofactor availability for noradrenaline biosynthesis.

74 Older patients had high plasma noradrenaline but attenuated adrenaline release with hig

75 abnormalities did not depend on the loss of noradrenaline but were abolished by the antiparkinsonian

76 To address whether noradrenaline can down-regulate TRPV1 channel activity i

77 Noradrenaline can modulate multiple cellular functions i

78 e neurons was found in locus coeruleus/A5/A7 noradrenaline cell groups, whereas the extent of neurona

79 the locus coeruleus and adjoining A5 and A7 noradrenaline cell groups.

80 ce interval [CI] = 1.009-1.20; P = 0.03) and noradrenaline compared to terlipressin (OR, 3.05; CI = 1

81 Use of noradrenaline compared to terlipressin was also predicti

82 9 versus 3.4 +/- 5.6 ng/mL*h, P = 0.03), and noradrenaline concentration (544 +/- 334 versus 402 +/-

83 that was evidenced by increased circulating noradrenaline concentration had little effect on HR, pot

84 f MAOA reversed the age-related reduction in noradrenaline concentration in adipose tissue, and resto

85 Circulating noradrenaline concentration increased from 0.9 +/- 0.4 n

86 .001) and reduced adrenaline (P < 0.001) and noradrenaline concentrations (P < 0.001).

87 cant hyperthermia, associated with increased noradrenaline concentrations in brown adipose tissue.

88 Under normoxaemic conditions plasma noradrenaline concentrations were lower in AD fetuses th

89 Adrenaline and noradrenaline concentrations were lower in the CW group

90 eptors and reveal a novel mechanism by which noradrenaline controls synaptic strength and plasticity

91 Adrenaline and noradrenaline correlated with syndecan-1 (r = 0.38, P <

92 e investigated potential mechanisms by which noradrenaline could directly influence the survival of a

93 Noradrenaline crucially modulates emotional memory.

94 The area under the noradrenaline curve (relative to the normoxia response)

95 t, carbachol delivery to parietal cortex, or noradrenaline delivery to either prefrontal or parietal

96 r RNA, alterations in synaptic strength, and noradrenaline-dependent and persistent depressive-like a

97 Noradrenaline-dependent plasticity affects the output of

98 Furthermore, noradrenaline did not elicit normal increases in lymphat

99 usion predicted that the functional range of noradrenaline diffusion was nearly fivefold greater in t

100 ent of corticotropin-releasing factor (CRF), noradrenaline, dopamine, glutamate, kappa/dynorphin, and

101 derived from the monoamine neurotransmitters noradrenaline, dopamine, serotonin, and histamine, and t

102 hemodynamic variables (time 0), we increased noradrenaline dose to elevate mean arterial pressure up

103 iverse behavioral results can be ascribed to noradrenaline-driven changes in neural dynamics.

104 e to propranolol, consistent with a dominant noradrenaline effect.

105 y facilitating the inhibitory control of the noradrenaline-excited neurons, histamine may inhibit the

106 normally be under the inhibitory control of noradrenaline-excited neurons.

107 The endogenous neurotransmitter noradrenaline exerts anti-inflammatory and neuroprotecti

108 Culturing rat pinealocytes in noradrenaline for 24 h induced a low-voltage activated t

109 B. bronchiseptica can use the catecholamine noradrenaline for growth on transferrin.

110 pharmacologically (tyramine, which displaces noradrenaline from axon terminals) induced vasoconstrict

111 ipocyte thermogenesis through the release of noradrenaline from local axons.

112 020) show that stress induces the release of noradrenaline from sympathetic nerves, which depletes th

113 signal in response to nocturnal delivery of noradrenaline from sympathetic neurons.

114 Blocking noradrenaline function (40 mg propranolol), in contrast,

115 ll show that in the dorsal cochlear nucleus, noradrenaline functions to simultaneously reduce spontan

116 ransmission mediated by serotonin, dopamine, noradrenaline, glycine and GABA (gamma-aminobutyric acid

117 such as serotonin, dopamine, histamine, and noradrenaline have important and varied physiological fu

118 ling from the stress hormones adrenaline and noradrenaline, have a lower incidence of prostate cancer

119 The addition of adrenaline, noradrenaline, hydrocortisone, or dexamethasone to lipop

120 comparing the efficacy of terlipressin with noradrenaline in ACLF patients with HRS.

121 hetic discharge, resulting in the release of noradrenaline in brown adipose tissue and white adipose

122 ent and animal studies points to the role of noradrenaline in dopaminergically insensitive aspects of

123 ision making and uncovers a specific role of noradrenaline in energizing behavior to face challenges.

124 ant role for the catecholamines dopamine and noradrenaline in meta-learning.

125 suggest that modulation of TRPV1 channels by noradrenaline in nociceptive neurons is a mechanism wher

126 Increasing mean arterial pressure with noradrenaline in septic shock patients improves density

127 secreting the catecholamines adrenaline and noradrenaline in the 'fight-or-flight' response.

128 to the locus coeruleus, the major source of noradrenaline in the brain, are histologically evident i

129 the locus coeruleus (LC), the main source of noradrenaline in the brain.

130 Transcription is recruited by noradrenaline in the hippocampus.

131 s in male mice, we show that the presence of noradrenaline in the olfactory bulb during acquisition r

132 We show here that noradrenaline in the olfactory bulb, the first cortical

133 eptor signaling via adrenergic nerve-derived noradrenaline in the prostate stroma is critical for act

134 In contrast, increasing the release of noradrenaline in the rat locus ceruleus prolonged the du

135 ceptor agonist, which decreases the level of noradrenaline in vivo, has an interesting effect in huma

136 ch binds the stress mediators adrenaline and noradrenaline, in modulating host response to mouse cyto

137 e invertebrate counterpart of adrenaline and noradrenaline, in synaptic and behavioral plasticity in

138 synthesis of the catecholamines dopamine and noradrenaline, in the brains of surface and cave Astyana

139 ce of Ca2+ channel activation and attenuated noradrenaline-induced G protein modulation.

140 ed synaptic transmission and also attenuated noradrenaline-induced G protein modulation.

141 Acute noradrenaline-induced hyperthermia requires UCP1 but not

142 The noradrenaline-induced T-type channel mediated an increas

143 Acting via the beta(3)-adrenergic receptors, noradrenaline induces lipolysis in white adipocytes, whe

144 We investigated whether noradrenaline induces plasticity at the glomerulus.

145 We propose that noradrenaline influences learning of uncertain events ar

146 After IgMIg administration, median noradrenaline infusion rates could be significantly redu

147 yte proliferation was inhibited after 2 h of noradrenaline infusion, and both catecholamines promoted

148 these findings, we propose that in the VLPO, noradrenaline-inhibited neurons may normally be under th

149 e-excited neurons, histamine may inhibit the noradrenaline-inhibited neurons, resulting in excitation

150 model emphasizes the role of focal glutamate-noradrenaline interactions in creating functional hotspo

151 Noradrenaline is also known to enhance episodic encoding

152 Noradrenaline is believed to support cognitive flexibili

153 e we probe the long-standing hypothesis that noradrenaline is involved in determining the uncertainty

154 ves extensive noradrenergic projections, and noradrenaline is released in the hippocampus in response

155 eruleus, we hypothesized that alterations in noradrenaline levels are a consequence of stress or dama

156 Several studies report that noradrenaline levels are altered in the central nervous

157 Since reduced noradrenaline levels could be permissive for increased i

158 mpathetic vasomotor tone (P < 0.001) and the noradrenaline levels in cerebrospinal fluid and plasma (

159 these results suggest that methods to raise noradrenaline levels or increase locus coeruleus functio

160 levels in sympathetic fibers and bone marrow noradrenaline levels rose (P<0.05, respectively), associ

161 human ovarian cancer samples, high tumoural noradrenaline levels were correlated with high pSrc(Y419

162 ease in astrocyte activation, a reduction in noradrenaline levels, and neuronal stress indicated by h

163 n rats, VNS elevates LC firing and forebrain noradrenaline levels, whereas LC lesions suppress VNS th

164 hese increases in modulation by dopamine and noradrenaline likely indicate changes in behavioral cont

165 glomerular filtration rate and plasma renin, noradrenaline, lipopolysaccharide binding protein, tropo

166 We find that the activation of the noradrenaline-locus coeruleus system (NOR-LC) during str

167 n nociceptive neurons is a mechanism whereby noradrenaline may suppress incoming noxious stimuli at t

168 Amine neurotransmitters, such as noradrenaline, mediate arousal, attention, and reward in

169 ron firing following a stressor depends on a noradrenaline-mediated mechanism.

170 Noradrenaline mediates the effects of different hormones

171 in several pro-oxidant molecules involved in noradrenaline metabolism.

172 ly low-quality evidence supported the use of noradrenaline, midodrine plus octreotide, and dopamine p

173 hat are stimulated with the neurotransmitter noradrenaline model the structure of the human heart aft

174 Noradrenaline modulates global brain states and diverse

175 pinealocytes is changed by culturing them in noradrenaline (NA) as a surrogate for the night signal.

176 responsible for the 'distal' effect by which noradrenaline (NA) blocks exocytosis in the beta-cell we

177 us ceruleus (LC) degeneration and subsequent noradrenaline (NA) deficiency in early Alzheimer's disea

178 direct role of M-channels in the release of noradrenaline (NA) from SNs.

179 and cognitive function, the specific role of noradrenaline (NA) in AD is not well understood.

180 The role of prefrontal noradrenaline (NA) in higher order flexibility indexed t

181 ations of monoamine neurotransmitter such as noradrenaline (NA) in living cells with simple, sensitiv

182 leus (LC) in the pons is the major source of noradrenaline (NA) in the brain.

183 essory OB (AOB), we have recently shown that noradrenaline (NA) increases GABA inhibitory input on to

184 chanism for long-term potentiation ABSTRACT: Noradrenaline (NA) is a neuromodulator that can effect l

185 Noradrenaline (NA) is hypothesized to play a key role in

186 Although noradrenaline (NA) reuptake inhibitors are shown to incr

187 Moreover, bath application of noradrenaline (NA) significantly depolarizes URS motoneu

188 Noradrenaline (NA) strengthens memory (re)consolidation.

189 raded intradermal microdialysis infusions of noradrenaline (NA) were measured during GnRH antagonist,

190 ation of endocytosis following exocytosis by noradrenaline (NA), a physiological inhibitor of insulin

191 Neurotransmitters, such as noradrenaline (NA), and neuropeptides, including nocicep

192 timulated release of preloaded radiolabelled noradrenaline (NA), dopamine (DA) and serotonin (5-HT) i

193 Noradrenaline (NA, non-selective alphaAR agonist) constr

194 lar conductance (FVC) to increasing doses of noradrenaline (NA; 2, 4 and 8 ng (100 ml)(-1) min(-1)) b

195 ons and that other neurotransmitter systems [noradrenaline (NE) and serotonin (5-HT)] were increased

196 Neuromodulatory systems such as noradrenaline (NE), acetylcholine (ACh), and serotonin (

197 thod that appeared not to be associated with noradrenaline nerve fibres.

198 In this assessment of dopamine and noradrenaline neuromodulatory effects we reveal their sp

199 t specific functional roles for dopamine and noradrenaline neurotransmission in the expression of inc

200 harmacological effects of stimulations using noradrenaline (NorA) as a modulator of functional activi

201 of the lateral calf for graded infusions of noradrenaline (norepinephrine) (NA; 10(-12) to 10(-2) m)

202 rmally grown sheep fetuses following a 7-day noradrenaline (norepinephrine) infusion.

203 al beta-adrenergic receptor stimulation with noradrenaline (norepinephrine; NA, 50 mul, 250 muM) was

204 , which emphasizes the qualitative effect of noradrenaline of updating the representation of the envi

205 Epigenetic regulation by noradrenaline offers a novel mechanism for long-term pot

206 s may function as mediators of the impact of noradrenaline on neuronal function.

207 wing that a single, simple network effect of noradrenaline on olfactory bulb dynamics can underlie th

208 th an emphasis on the quantitative effect of noradrenaline on stimulus processing.

209 blocked with KN-93, the inhibitory effect of noradrenaline on the capsaicin-activated current was gre

210 The inhibitory effect of noradrenaline on the capsaicin-activated current was not

211 The inhibitory effect of noradrenaline on TRPV1 channels was dependent on calcium

212 o major stress neuromodulators, cortisol and noradrenaline, on loss aversion during financial decisio

213 Noradrenaline or clonidine inhibited the capsaicin-activ

214 enic T cells that had been preincubated with noradrenaline or splenocytes harvested from stressed mic

215 d vasoactive therapy-dopamine, and if needed noradrenaline) or intracranial pressure-targeted therapy

216 th physiological doses of either adrenaline, noradrenaline, or cortisol via i.v. infusion for 48 h.

217 hat increased sympathetic nerve activity and noradrenaline outflow associated with hypertension may b

218 h low-quality evidence supporting the use of noradrenaline over placebo (4.17, 1.37-12.50) and over m

219 Older trauma patients had markedly higher noradrenaline (p < .001) but an attenuated increase in a

220 ertebrate homolog of mammalian adrenaline or noradrenaline, plays important roles in modulating behav

221 lb (MOB) is richly targeted by LC fibers and noradrenaline profoundly influences MOB circuitry and od

222 and increase 3-methoxy-4-hydroxyphenylglycol/noradrenaline ratio.

223 administered 40 mg atomoxetine, a selective noradrenaline re-uptake inhibitor to 25 patients with Pa

224 ants and the newer, safer class of serotonin/noradrenaline re-uptake inhibitors, for example duloxeti

225 inals are found in the glomerular layer, but noradrenaline receptors do not seem to acutely modulate

226 oreceptors in brain in vivo, here applied to noradrenaline receptors in rat brain.

227 raction of resistance vessels is enhanced by noradrenaline release along perivascular sympathetic ner

228 al air puff triggered transient increases in noradrenaline release and large cytosolic astrocytic Ca(

229 a glutamate "priority" signal that modulates noradrenaline release depending on arousal state.

230 We conclude that noradrenaline release from LC has persistent effects on

231 rm potentiation in vivo and on AMPA-mediated noradrenaline release were measured to predict its poten

232 hich indexes neuromodulatory state including noradrenaline release, predicted increases (but not decr

233 prediction error-reflected in LC firing and noradrenaline release-to optimise learning rate, enablin

234 lanation: that priority itself evokes phasic noradrenaline release.

235 allow modulation of endocrine adrenaline and noradrenaline release.

236 been attributed to the beneficial effects of noradrenaline released into the amygdala attributable to

237 roteins on binding the agonists adenosine or noradrenaline, respectively.

238 tcomes with serotonin reuptake inhibiting or noradrenaline reuptake inhibiting antidepressants and av

239 Parkinson's disease found that the selective noradrenaline reuptake inhibitor atomoxetine could impro

240 f action of methylphenidate, infusion of the noradrenaline reuptake inhibitor atomoxetine into these

241 erefore examined the effect of the selective noradrenaline reuptake inhibitor atomoxetine on response

242 The noradrenaline reuptake inhibitor reboxetine attenuates e

243 this approach using atomoxetine, a selective noradrenaline reuptake inhibitor that modulates the pref

244 Atomoxetine (ATO), a selective noradrenaline reuptake inhibitor, had no effect on respo

245 tonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and tricyclic

246 NNTs were 6.4 (95% CI 5.2-8.4) for serotonin-noradrenaline reuptake inhibitors, mainly including dulo

247 s overall, serotonin reuptake inhibitors, or noradrenaline reuptake inhibitors, or differential respo

248 ain for tricyclic antidepressants, serotonin-noradrenaline reuptake inhibitors, pregabalin, and gabap

249 aturated as a consequence of a dysfunctional noradrenaline reuptake mechanism.

250 vealed that this may be due to dysfunctional noradrenaline reuptake.

251 serotonin-reuptake inhibitors and serotonin-noradrenaline-reuptake inhibitors, are effective, and th

252 ee of sympathetic nervous system activation (noradrenaline, rho = 0.26, P = 0.05; heart rate variabil

253 regulation; (iv) neurotransmitter (dopamine, noradrenaline, serotonin) expressions, transporter or re

254 d effects of invasive VNS on locus coeruleus-noradrenaline signaling, and support that tVNS mimics VN

255 We found that noradrenaline simultaneously reduced spontaneous inhibit

256 Noradrenaline strongly inhibited the activity of TRPV1 c

257 lability of BH(4) and/or tyrosine may impair noradrenaline synthesis and contribute to the attenuated

258 Compared to noradrenaline, terlipressin achieved greater day 4 (26.1

259 blunted methamphetamine and fully inhibited noradrenaline thermogenesis, but an increased febrile re

260 rs in mature BAT, increasing the response to noradrenaline through enhanced p38MAPK/CREB signaling an

261 ting sympathoadrenal activation (adrenaline, noradrenaline), tissue/endothelial cell/glycocalyx damag

262 for the enzyme responsible for conversion of noradrenaline to adrenaline.

263 nergic inputs may constitute a mechanism for noradrenaline to modulate incoming noxious stimuli in th

264 o the host NE stress hormones adrenaline and noradrenaline to modulate virulence.

265 of monoamine oxidase A, restored hippocampal noradrenaline to normal levels (from 60 to 97% of vehicl

266 Intratumoral adrenergic nerves release noradrenaline to stimulate angiogenesis via VEGF signali

267 isms underlying somatodendritic dopamine and noradrenaline transmission and found that the extent of

268 We show that while inhibition of noradrenaline transmission during an odor-reward acquisi

269 studies indicate the involvement of CRF and noradrenaline transmission in bed nucleus of stria termi

270 and pupil diameter as a proxy measure for LC-noradrenaline transmission, indicate increased encoding-

271 al, we have engineered HSV1716 to convey the noradrenaline transporter (NAT) gene (HSV1716/NAT), whos

272 is compensated for by the expression of the noradrenaline transporter (NAT) gene, and not the seroto

273 t of human SK-N-BE(2c) neuroblastoma and UVW/noradrenaline transporter (NAT) glioma cells.

274 erm DNA damage and supraadditive toxicity to noradrenaline transporter (NAT)-expressing cells and xen

275 d by the serotonin transporter (SERT) or the noradrenaline transporter (NET) inhibitors citalopram an

276 G to spheroids and xenografts expressing the noradrenaline transporter.

277 osine hydroxylase expression and that of the noradrenaline transporter; and enhanced expression and s

278 C activation was also found with recombinant noradrenaline transporters and in rat hippocampal slices

279 d PET with (11)C-MeNER to map the density of noradrenaline transporters in groups of patients with PD

280 )C-MeNER) is a highly selective inhibitor of noradrenaline transporters, and PET studies suggest that

281 The dopamine and noradrenaline transporters, together with SERT, are memb

282 essin-treated patients, and 33% (range 6-40) noradrenaline-treated patients with reversal of hepatore

283 ency of Ca(2+) oscillations induced by 1 muM noradrenaline was 150% higher than in the wild-type.

284 Furthermore, noradrenaline was an independent predictor of <24-hours

285 Noradrenaline was as effective as terlipressin for the t

286 tion was enhanced in male CF mice, and renal noradrenaline was increased in female CF mice.

287 Inhibition of capsaicin-activated current by noradrenaline was mediated by GTP binding proteins, and

288 The effect of noradrenaline was reproduced by clonidine and antagonize

289 neuroendocrine (NE) hormones adrenaline and noradrenaline were reported to display cross-talk for th

290 disease, cortical and spinal cord levels of noradrenaline were significantly reduced versus control

291 oth groups, concentrations of adrenaline and noradrenaline were unchanged through low- and moderate-e

292 um-22 attenuated the removal of 5-HT but not noradrenaline, whereas desipramine had the reverse actio

293 The second group comprised adrenaline and noradrenaline which displayed higher intrinsic activity

294 e loss of other neurotransmitters, including noradrenaline, which is linked to impulsivity and respon

295 engaging the stress hormone/neurotransmitter noradrenaline, which mediates and modulates the consolid

296 e, sympathetic nerve fibers released surplus noradrenaline, which signaled bone marrow niche cells to

297 ific immune cells are activated by increased noradrenaline, while others are in fact suppressed.

298 Terlipressin with albumin and noradrenaline with albumin are both superior to midodrin

299 Thus, cotransmission of dopamine and noradrenaline with either GABA or glutamate appears to b

300 essin gives earlier and higher response than noradrenaline, with improved survival in ACLF patients w